A series of problems including osteopathy, abnormal serum data, and vascular calcification
associated with chronic kidney disease (CKD) are now collectively called CKD-mineral bone …

Impaired kidney function and subsequent skeletal responses play a critical role in disrupting
phosphate balance in chronic kidney disease (CKD) patients with mineral and bone …

The vertebrate endoskeleton is not a mere frame for muscle attachment to facilitate
locomotion, but is a massive organ integrated with many physiologic functions including …

The pathogenesis and management of chronic kidney disease-mineral bone disorders
(CKD-MBD) has experienced major changes, but the control of serum phosphorus at all …

Recent studies have identified a novel bone− kidney endocrine axis that maintains
phosphate homeostasis. When phosphate is in excess, fibroblast growth factor-23 (FGF23) …

Chronic kidney disease mineral bone disorder (CKD-MBD) is a common co-morbidity in
patients with CKD. Characterized by laboratory abnormalities, bone abnormality, and …

The CKD mineral bone disorder is a new term coined to describe the multiorgan system
failure that is a major component of the excess cardiovascular mortality and morbidity …

Hyperphosphatemia is common in chronic kidney disease (CKD). Often seen as the “silent
killer” because of its dramatic effect on vascular calcifications, hyperphosphatemia explains …

In the development of 'chronic kidney disease–mineral bone disorder'(CKD–MBD), the
current discussion ranks around the phrase 'which comes first'[1, 2]: calcitriol deficiency …

Abnormal mineral metabolism is a hallmark in patients with advanced chronic kidney
disease (CKD). Hyperphosphatemia, and the homeostatic mechanisms controlling …